MODULAR COMBINATION OF MEDICATION INFUSION AND ANALYTE MONITORING

• US 20170296740A1
• Filed: 05/01/2017
• Published: 10/19/2017
• Est. Priority Date: 02/19/2007
• Status: Abandoned Application

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Hoss, Udo, Stafford, Gary A.
• Application Number:
  US15/582,878
• Publication Number:
  US 20170296740A1
• Time in Patent Office: Days
• CPC Class Codes: A61M 2005/14268 with a reusable and a disposable component
• CPC Class Codes: A61M 2005/1726 the body parameters being measured at, or proximate to, the infusion site
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1452 pressurised by means of pistons
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61M 5/365 Air detectors A61M5/1684 takes precedence; in extracorporeal blood circuits A61M1/3626

Abstract

Methods and systems for providing modular components in an integrated infusion device and analyte monitoring system where the components are independently repleaceable are provided.

Claims

1. A method, comprising:

positioning a replaceable first modular component on a skin surface of a user;

connecting a replaceable second modular component to a predetermined location on the first modular component during a first time period, wherein a water tight seal is formed between the first modular component and the second modular component;

connecting a third modular component to the predetermined location first modular component during a second time period, wherein a water tight seal is formed between the first modular component and the third modular component;

wherein the first time period and the second time period are nonoverlapping.

2. The method of claim 1 including:

delivering medication to the user; and

monitoring analyte level of the user.

3. The method of claim 1 wherein the analyte includes glucose.

4. A kit, comprising:

an infusion device configured to deliver medication, the infusion device including a port;

an analyte monitoring device configured to monitor an analyte level of a user, the analyte monitoring device connectable to the port of the infusion device during a first predetermined time period;

a cap connectable to the port of the infusion device during a second predetermined time period;

wherein the first and second predetermined time periods are overlapping.

5. The kit of claim 4 wherein the analyte includes glucose.

6. The kit of claim 4 wherein the infusion device includes an on-body patch pump.

7. The kit of claim 4 wherein the cap provides a water tight seal on the port when connected to the infusion device.

8. The kit of claim 4 wherein the analyte monitoring device provides a water tight seal on the port when connected to the infusion device.